Lung microbiota: implications and interactions in chronic pulmonary diseases
Jing Zhou1, Wang Hou1, Huilin Zhong1
1Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in Cellular and Infection Microbiology
|September 5, 2024
Summary
The lung microbiota impacts lung diseases like COPD and asthma. Understanding these microbial communities is key to developing new treatments for respiratory conditions.
Area of Science:
- Microbiology
- Pulmonology
- Immunology
Background:
- The lung microbiota plays a crucial role in maintaining respiratory health and homeostasis.
- Alterations in the lung microbial community (dysbiosis) are linked to the development and progression of chronic lung diseases.
- Key lung diseases influenced by microbiota changes include COPD, IPF, asthma, and lung cancer.
Purpose of the Study:
- To review current research on the lung microbiota and its connection to lung diseases.
- To explore methodological advancements in studying the lung microbiota.
- To summarize the impact of lung microbiota on disease pathogenesis and discuss research approaches.
Main Methods:
- Literature review of recent studies on lung microbiota and lung diseases.
- Analysis of research methodologies for investigating lung microbiota composition and function.
- Synthesis of findings on host-microbe interactions in the context of respiratory health and disease.
Main Results:
- Changes in lung microbiota composition are associated with major chronic lung diseases.
- Methodological challenges exist due to the small scale and environmental sensitivity of lung microbiota.
- Advancements in research methods are improving our understanding of these complex interactions.
Conclusions:
- The lung microbiota is a significant factor in the development and progression of lung diseases.
- Further research into lung microbiota mechanisms and improved study methods are essential for therapeutic advancements.
- Understanding the lung microbiome offers potential for novel diagnostic and therapeutic strategies for respiratory conditions.
Keywords:
chronic obstructive pulmonary disease (COPD)chronic pulmonary diseaseslung microbiotamicrobial genomicsmicrobial metabolomicsMore Related Videos
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
500
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
10.7K
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K